Akari Therapeutics, Plc

Akari Therapeutics, Plc

AKTX
Akari Therapeutics, PlcUS flagNASDAQ Capital Market
9.30
USD
-1.36
- -
10.64MMarket Cap

Akari Therapeutics, Plc (AKTX) Stock Split History

Learn about Akari Therapeutics, Plc's most recent 1-for-40 basis stock split on March 31, 2026. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Akari Therapeutics, Plc's most recent stock split

Split Date: 2026-03-31
Split Ratio: 1:40
Price Before Split: $0.13
Price After Split: $0.00

Developer API

Get AKTX split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/AKTX

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 40.00 times fewer shares (a 1:40 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Akari Therapeutics, Plc's stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2026-03-311:40Yes$0.13$0.00
2023-08-171:20Yes$0.15$0.01
2015-09-171:10Yes$1.97$0.20
2014-01-031:5YesN/AN/A

About Akari Therapeutics, Plc

Company overview and industry information

Akari Therapeutics, Plc (AKTX) operates in the Biotechnology industry. The recent 1-for-40 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Akari Therapeutics, Plc Summary

Last updated: 7/22/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.